Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Elevated levels of C-reactive protein (CRP) are associated with increased risks of ischemic heart disease and ischemic cerebrovascular disease. We tested whether this is a causal association. METHODS: We studied 10,276 persons from a general population cohort, including 1786 in whom ischemic heart disease developed and 741 in whom ischemic cerebrovascular disease developed. We examined another 31,992 persons from a cross-sectional general population study, of whom 2521 had ischemic heart disease and 1483 had ischemic cerebrovascular disease. Finally, we compared 2238 patients with ischemic heart disease with 4474 control subjects and 612 patients with ischemic cerebrovascular disease with 1224 control subjects. We measured levels of high-sensitivity CRP and conducted genotyping for four CRP polymorphisms and two apolipoprotein E polymorphisms. RESULTS: The risk of ischemic heart disease and ischemic cerebrovascular disease was increased by a factor of 1.6 and 1.3, respectively, in persons who had CRP levels above 3 mg per liter, as compared with persons who had CRP levels below 1 mg per liter. Genotype combinations of the four CRP polymorphisms were associated with an increase in CRP levels of up to 64%, resulting in a theoretically predicted increased risk of up to 32% for ischemic heart disease and up to 25% for ischemic cerebrovascular disease. However, these genotype combinations were not associated with an increased risk of ischemic vascular disease. In contrast, apolipoprotein E genotypes were associated with both elevated cholesterol levels and an increased risk of ischemic heart disease. CONCLUSIONS: Polymorphisms in the CRP gene are associated with marked increases in CRP levels and thus with a theoretically predicted increase in the risk of ischemic vascular disease. However, these polymorphisms are not in themselves associated with an increased risk of ischemic vascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional biomarkers, including apo B, lipoprotein(a), high-sensitivity C-reactive protein (CRP), coronary artery calcification score, and ankle-brachial index, are independent risk factors associated with increased risk of ASCVD events and may be helpful when the lipid management goal is unclear.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [284]
In the citing paper
“The value of hsCRP as a CV risk factor appears similar to that of conventional CV risk factors – hsCRP is not a causal factor for CV disease and serves as a biomarker only [36].”
From Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials (2022) · cites this paper as [36]
In the citing paper
“PAD is a common manifestation of atherosclerosis and such patients are at elevated risk of coronary events, with PAD representing an independent risk factor for MI and CV death [510,511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
In the citing paper
“PAD is a common manifestation of atherosclerosis and such patients are at elevated risk of coronary events, with PAD representing an independent risk factor for MI and CV death [510,511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
In the citing paper
“Yet, despite the high CV morbidity and mortality risk, PAD patients are usually inadequately managed compared with CAD patients [511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citationFasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.76 · Cited by 1,585
Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F., Havulinna, A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.75 · Cited by 1,386
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Cited by
Items 401–500 of 840
The Inherited Basis of Coronary Artery Disease
Schunkert, H., Natarajan, P., & Samani, N. J. (2026) · New England Journal of Medicine · doi:10.1056/nejmra2405153 · Cited by 26
Lorenzatti, A. J., & Retzlaff, B. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.061 · Cited by 25
Use of Mendelian randomization to better understand and treat sepsis
Russell, J. A., Meyer, N. J., & Walley, K. R. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06778-y · Cited by 25
Kjaergaard, A. D., Nordestgaard, B. G., Johansen, J. S., & Bojesen, S. E. (2015) · International Journal of Cancer · doi:10.1002/ijc.29638 · Cited by 23
Self-citationPharmacological modulation of vascular inflammation in atherothrombosis
Caterina, R. D., Massaro, M., Scoditti, E., & Carluccio, M. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05784.x · Cited by 25
Schwab, S., Zierer, A., Schneider, A. L. C., Heier, M., Köenig, W., Kastenmüller, G., Waldenberger, M., Peters, A., & Thorand, B. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000902 · Cited by 24
Genetic contribution to C-reactive protein levels in severe obesity
Faucher, G., Guénard, F., Bouchard, L., Garneau, V., Turcot, V., Houde, A., Tchernof, A., Bergeron, J., Deshaies, Y., Hould, F., et al. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.198 · Cited by 27
“While CRP was suggested to play an active role in the pathogenesis of atherosclerosis [58,59], recent large studies provided evidence arguing against a causal role [54,60].”
ResultLiu, S., Zhong, Y., You, X., Liu, W., Li, A., & Liu, S. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1828-y · Cited by 23
CRP Polymorphisms and Progression of Chronic Kidney Disease in African Americans
Hung, A. M., Crawford, D. C., Griffin, M. R., Brown-Gentry, K. D., Lipkowitz, M. S., Siew, E. D., Cavanaugh, K. L., Lewis, J. B., & Ikizler, T. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01900309 · Cited by 26
Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study
Mayer, F., Binder, C. J., Wagner, O. F., Schillinger, M., Minar, E., Mlekusch, W., Tsiantoulas, D., Goliasch, G., & Hoke, M. (2016) · Stroke · doi:10.1161/strokeaha.116.013647 · Cited by 23
Straczek, C., Ducimetière, P., Barberger‐Gateau, P., Helmer, C., Ritchie, K. A., Jouven, X., Carcaillon‐Bentata, L., Amouyel, P., Tzourio, C., & Empana, J. P. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02625.x · Cited by 23
Breitling, L. P., Köenig, W., Fischer, M., Mallat, Z., Hengstenberg, C., Rothenbacher, D., & Brenner, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022318 · Cited by 24
Kjaergaard, A. D., Johansen, J. S., Nordestgaard, B. G., & Bojesen, S. E. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101908 · Cited by 23
Self-citationYasuma, T. R., Nakamura, M., Nishiguchi, K. M., Kikuchi, M., Kaneko, H., Niwa, T., Hamajima, N., & Terasaki, H. (2010) · PubMed Central · Cited by 26
Paradoxical Association of C-Reactive Protein with Endothelial Function in Rheumatoid Arthritis
Holmes, M. V., Jiang, B., McNeill, K. L., Wong, M., Oakley, S. P., Kirkham, B. W., & Chowienczyk, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010242 · Cited by 24
Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis
Minard, L. V., Corkum, A., SKETRIS, I. S., Fisher, J. E., Zhang, Y., & Saleh, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158608 · Cited by 22
Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes
Hermans, M. P., Ahn, S. A., & Rousseau, M. F. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107413 · Cited by 26
Zeng, X., Zhang, G., Yang, B., Zhang, B., Zhang, L., Ni, Y., Liu, C., & Luo, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9310-3 · Cited by 22
Martínez-Calleja, A., Quiróz-Vargas, I., Parra‐Rojas, I., Muñóz-Valle, J. F., Leyva‐Vázquez, M. A., Fernández‐Tilapa, G., Vences-Velázquez, A., Cruz, M., Salazar-Martínez, E., & Flores‐Alfaro, E. (2012) · Experimental Diabetes Research · doi:10.1155/2012/982683 · Cited by 29
Varga, J. T., Pálinkás, A., Lajkó, I., Horváth, I., Boda, K., & Somfay, A. (2016) · The Open Respiratory Medicine Journal · doi:10.2174/1874306401610010001 · Cited by 23
Matsuda, S., Yamashita, A., Sato, Y. Z., Kitajima, S., Koike, T., Sugita, C., Moriguchi‐Goto, S., Hatakeyama, K., TAKAHASHI, M., Koshimoto, C., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04086.x · Cited by 24
Genetic Polymorphisms and the Cardiovascular Risk of Non-Steroidal Anti-Inflammatory Drugs
Germaine, C. G. S., Bogaty, P. M., Boyer, L., Hanley, J. A., Engert, J. C., & Brophy, J. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.352 · Cited by 25
C-Reactive Protein, Fibrinogen, and Cardiovascular Risk
Kaptoge, S., Thompson, S. G., & Danesh, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1213688 · Cited by 22
Mahmoudi, A. A., Katsiki, N., Vrablík, M., & SAHEBKAR, A. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01386-9 · Cited by 22
Anti-Inflammatory Therapy in Coronary Artery Disease: Where Do We Stand?
Rakočević, J., Dobric, M. R., Labudović‐Borović, M., Milutinović, K., Milenkovic, S., & Tomasevic, M. V. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2401010 · Cited by 25
Thanassoulis, G. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.09.014 · Cited by 22
Akinlade, K. S., Atere, A. D., Olaniyi, J. A., Rahamon, S. K., & Adewale, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077913 · Cited by 23
Advances in endothelial shear stress proteomics
Firasat, S., Hecker, M., Binder, L., & Asif, A. R. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.933673 · Cited by 22
Yang, D. H., Kang, J., Kim, H., Choe, J., Baek, S., Kim, S. H., Park, G., Kim, Y., Kim, T., Tseng, W. I., et al. (2014) · Radiology · doi:10.1148/radiol.14130772 · Cited by 21
NOD2/CARD15 genotype and common gastrointestinal diseases in 43 600 individuals
Yazdanyar, S., & Nordestgaard, B. G. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02137.x · Cited by 21
Self-citationKaur‐Knudsen, D., Bojesen, S. E., & Nordestgaard, B. G. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.34 · Cited by 20
Self-citationAramburu‐Bodas, Ó., García-Casado, B., Salamanca‐Bautista, P., Espartero, M. E. G., Arias‐Jiménez, J. L., Barco-Sánchez, A., Santamaría-González, J. C., Formiga, F., Montero-Pérez-Barquero, M., & Manzano, L. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000229 · Cited by 21
Matrix Metalloproteinase-3 Gene Polymorphisms Are Associated with Ischemic Stroke
Kim, S. K., Kang, S. W., Kim, D. H., Yun, D. H., Chung, J., & Ban, J. Y. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0022 · Cited by 20
Assayag, E. B., Shenhar‐Tsarfaty, S., Bova, I., Berliner, S. A., Usher, S., Peretz, H., Shapira, I., & Bornstein, N. M. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.04.008 · Cited by 23
“They found that genetic CRP variants explained a difference in plasma CRP levels of up to 64% [9].”
BackgroundIs it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease?
Hingorani, A. D., Sofat, R., Morris, R. W., Whincup, P. H., Lowe, G. D. O., Mindell, J. S., Sattar, N. A., Casas, J. P., & Shah, T. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs168 · Cited by 23
Li, W., Xiong, L., Fan, L., Wang, Y., Peng, X., Rong, R., Qiu, Y., Shen, J., Lin, J., Yu, X., et al. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0624-4 · Cited by 21
Possible positive effect of the APOE ε2 allele on cognition in early to mid-adult life
Sinclair, L. I., Pleydell-Pearce, C. W., & Day, I. N. M. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.10.008 · Cited by 22
Zhang, Y., Li, M., Zhang, L., Li, Q., Yang, P., Kong, X., Duan, X., Zhang, M., Li, X., Wang, Y., et al. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-04992-x · Cited by 20
Reversible promoter methylation determines fluctuating expression of acute phase proteins
Zhang, S., Wang, M., Feng, J.-R., Chang, Y., Ji, S., & Wu, Y. (2020) · eLife · doi:10.7554/elife.51317 · Cited by 21
Bertoméu, V., & González‐Juanatey, J. R. (2009) · American Journal of Cardiovascular Drugs · doi:10.2165/1153161-s0-000000000-00000 · Cited by 21
Fibrinogen and α1-antitrypsin in COPD exacerbations
Ingebrigtsen, T. S., Marott, J. L., Rode, L., Vestbo, J., Lange, P., & Nordestgaard, B. G. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207561 · Cited by 24
Self-citationAssociation of plasma C‐reactive protein with ischaemic stroke: a Mendelian randomization study
Zhang, X., Wang, A., Zhang, J., Singh, M., Liu, D., Zuo, Y., Wu, L., Song, M., Wang, W., Feigin, V. L., et al. (2019) · European Journal of Neurology · doi:10.1111/ene.14113 · Cited by 21
“in European ancestry individuals that the CRP concentration plays a major role in the development of IS [9,10].”
BackgroundNo evidence of increased risk of thyroid dysfunction in well treated people living with HIV
Harsløf, M., Knudsen, A. D., Benfield, T., Nordestgaard, B. G., Feldt-Rasmussen, U., & Nielsen, S. D. (2018) · AIDS · doi:10.1097/qad.0000000000001954 · Cited by 19
Self-citationShishido, T., Konta, T., Nishiyama, S., Miyashita, T., Miyamoto, T., Takasaki, S., Nitobe, J., Watanabe, T., Takeishi, Y., & Kubota, I. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.531837 · Cited by 19
Thomsen, M. J., Dahl, M., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02447.x · Cited by 19
Self-citationJUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?
Shishehbor, M. H., & Hazen, S. L. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75a.08105 · Cited by 22
Khera, A. V., & Rader, D. J. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.12.003 · Cited by 19
Tanasković, S., Isenović, E. R., & Radak, D. J. (2011) · Angiology · doi:10.1177/0003319710398010 · Cited by 19
Xia, M. X., Zhang, C., Gu, J., Chen, J., Wang, L., Lu, Y., Huang, C., He, Y., & Yang, X. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.02.025 · Cited by 19
Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future
Wang, L., Zhang, Y., & Zhang, S. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000530 · Cited by 28
Nordestgaard, A. T., Nordestgaard, B. G., Frikke‐Schmidt, R., Rasmussen, I. J., & Bojesen, S. E. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.022 · Cited by 20
Self-citationLipoprotein‐associated phospholipase A2 and cardiovascular disease risk in HIV infection
Eckard, A. R., Longenecker, C. T., Jiang, Y., Debanne, S., Labbato, D. E., Storer, N. J., & McComsey, G. (2014) · HIV Medicine · doi:10.1111/hiv.12143 · Cited by 20
Kim, Y. S., Sung, Y., Choi, C., Uhm, W.-S., Kim, T., Shin, J., & Jun, J. (2011) · Rheumatology International · doi:10.1007/s00296-011-2198-y · Cited by 19
Rojo‐Martínez, G., Soriguer, F., Colomo, N., CALLE, A. L., Goday, A., Bordiú, E., Delgado, E., Torre, E. L. M., Ortega, E., Urrutia, I., et al. (2012) · European Journal of Clinical Investigation · doi:10.1111/eci.12002 · Cited by 19
Melichar, B., Kalábová, H., Krčmová, L. K., Urbánek, L., Hyšpler, R., Solichová, D., Melicharová, K., Pecka, M., & Zadák, Z. (2009) · PubMed · Cited by 23
Zacho, J., Benfield, T., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.249680 · Cited by 22
Self-citationBody mass index: Has epidemiology started to break down causal contributions to health and disease?
Corbin, L. J., & Timpson, N. J. (2016) · Obesity · doi:10.1002/oby.21554 · Cited by 21
Role of enteric dysbiosis in the development of central obesity: A review
Obayomi, O. V., Olaniran, A. F., Olawoyin, D. C., Falade, O. V., Osemwegie, O. O., & Owa, S. O. (2024) · Scientific African · doi:10.1016/j.sciaf.2024.e02204 · Cited by 22
Elevated Remnant and LDL Cholesterol and the Risk of Peripheral Artery Disease
Wadström, B. N., Borges, M. C., Wulff, A. B., Smith, G. D., Sanderson, E. C. M., & Nordestgaard, B. G. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.12.033 · Cited by 19
Self-citationInfluence of Low-Grade Inflammation on Plasma B-type Natriuretic Peptide Levels
Inoue, T., Kawai, M., Nakane, T., Nojiri, A., Minai, K., Komukai, K., Ogawa, T., Hongo, K., Matsushima, M., & Yoshimura, M. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.4211 · Cited by 18
Martin, S. S., Qasim, A., Rader, D. J., & Reilly, M. P. (2011) · Obesity · doi:10.1038/oby.2011.164 · Cited by 18
Nozari, Y., & Geraiely, B. (2011) · PubMed · Cited by 18
Sheu, W. H., Wang, W., Wu, K., He, C., Hwu, C., Quertermous, T., Hsieh, W.-S., Lee, W., Ting, C.-T., Chen, Y. I., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08696-2 · Cited by 18
High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction
Pokharel, Y., Sharma, P. P., Qintar, M., Lu, Y., Tang, Y., Jones, P. G., Dreyer, R. P., & Spertus, J. A. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.09.019 · Cited by 19
PROGRESS IN UREMIC TOXIN RESEARCH: C‐Reactive Protein and Uremia
Wanner, C., Drechsler, C., & Krane, V. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00596.x · Cited by 18
Liu, D., Qi, X., Li, Q., Jia, W., Wei, L., Huang, A., Liu, K., & Li, Z. (2016) · Biomedical Reports · doi:10.3892/br.2016.793 · Cited by 18
Eltoft, A., Arntzen, K. A., Wilsgaard, T., Hansen, J., Mathiesen, E. B., & Johnsen, S. H. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008951 · Cited by 18
Rasmussen, K. L., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2016) · Data in Brief · doi:10.1016/j.dib.2016.01.060 · Cited by 18
Self-citationYang, X., He, X., Li, G., & Xu, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175507 · Cited by 17
Baars, T., Gieseler, R. K. H., Patsalis, P., & Canbay, A. E. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155179 · Cited by 19
Mölkänen, T., Rostila, A., Ruotsalainen, E., Alanne, M., Perola, M., & Järvinen, A. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0978-z · Cited by 17
“mellitus [15]. However, the causative effect of the cisacting SNPs on ischemic heart disease remains under some controversy [ 16 ].”
BackgroundRegulated conformation changes in C-reactive protein orchestrate its role in atherogenesis
Ma, X., Ji, S., & Wu, Y. (2012) · Chinese Science Bulletin · doi:10.1007/s11434-012-5591-3 · Cited by 18
Gałecki, P., Talarowska, M. E., Moczulski, D. K., Bobińska, K., Opuchlik, K., Gałecka, E., Florkowski, A., & Lewiñski, A. (2013) · PubMed · Cited by 18
Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
Lorenzatti, A. J. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.51 · Cited by 18
Familial Mediterranean fever gene mutations as a risk factor for early coronary artery disease
Başar, N., Kısacık, B., Ercan, S., Pehlivan, Y., Yılmaz, S., Şimşek, İ., Erdem, H., Özer, O., Pay, S., Onat, A. M., et al. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12356 · Cited by 17
Lipoprotein(a) in various conditions: To keep a sense of proportions
Kronenberg, F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.054 · Cited by 17
“These findings supported CRP as risk marker (and not a risk factor) that might not be causally related to cardiovascular disease [17].”
BackgroundHu, M., Lee, M. H. K., Mak, V. W. L., & Tomlinson, B. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.07.044 · Cited by 17
Abbasi, S. H., & Boroumand, M. A. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004020038 · Cited by 20
Melichar, B., Kalábová, H., Krčmová, L. K., Kašparová, M., Malířová, E., Melicharová, K., Pecka, M., Hyšpler, R., & Solichová, D. (2009) · PubMed · Cited by 19
Missing Data Methods in Mendelian Randomization Studies With Multiple Instruments
Burgess, S., Seaman, S. R., Lawlor, D. A., Casas, J. P., & Thompson, S. G. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr235 · Cited by 17
Kobylecki, C. J., Nordestgaard, B. G., & Afzal, S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac146 · Cited by 16
Self-citationGenetic Variants, Immune Function, and Risk of Pre‐Eclampsia among American Indians
Best, L. G., Nadeau, M., Davis, K., Lamb, F., Bercier, S., & Anderson, C. M. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01076.x · Cited by 17
Delui, M. H., Fatehi, H., Manavifar, M., Amini, M., Ghayour‐Mobarhan, M., Zahedi, M., & Ferns, G. A. (2013) · Europe PMC (PubMed Central) · Cited by 16
Keller‐Baruch, J., Forgetta, V., Manousaki, D., Zhou, S., & Richards, J. B. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3937 · Cited by 19
“MR has been previously used to investigate the causal role of high-density lipoprotein((18)) and C-reactive protein((19)) in predisposition to cardiovascular disease and has provided evidence that PCSK9 inhibition prevents cardiovascular disease.”
MethodDas, S., Roy, S., Kaul, S., Jyothy, A., & Munshi, A. (2014) · Inflammation · doi:10.1007/s10753-014-9897-y · Cited by 17
Eldrup, N., Kragelund, C., Steffensen, R., & Nordestgaard, B. G. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.11.003 · Cited by 16
“Because elevated levels of CRP per se do not appear to lead to increased risk of cardiovascular disease [15], it seems more likely that the elevated CRP levels is a marker for inflamed atherosclerotic plaques with a high risk of rupture [16] leading to the observed increased risk of unstable angina, myocardial infarct…”
BackgroundSelf-citationAssa, S., Kuipers, J., Ettema, E. M., Gaillard, S., Krijnen, W. P., Hummel, Y. M., Voors, A. A., van Melle, J. P., Westerhuis, R., Willemsen, A. T. M., et al. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00368.2017 · Cited by 16
Heritable confounding of exposure and outcome in Mendelian randomization studiesPreprint
Sanderson, E. C. M., Rosoff, D. B., Vitt, N., Palmer, T., Tilling, K. M., Smith, G. D., & Hemani, G. (2024) · medRxiv · doi:10.1101/2024.09.05.24312293 · Cited by 20
CRP gene polymorphism predicts post-stroke functional outcome in Han Chinese
Guo, J., Yu, L., Zhang, J., Chen, N., Zhou, M., & He, L. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12180 · Cited by 15
The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions
Spence, J. D. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)71060-6 · Cited by 15
Grammer, T. B., Hoffmann, M. M., Renner, W., Kleber, M. E., Winkelmann, B. R., Boehm, B. O., & März, W. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.005 · Cited by 17
Ghattas, M. H., Abo–Elmatty, D. M., & El-Eraky, A. Z. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283577170 · Cited by 15
Kleber, M. E., Grammer, T. B., Renner, W., & März, W. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-157 · Cited by 15
Fonseca, F. A. H., & Izar, M. C. D. O. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.93 · Cited by 15
Genetic variation in C ‐reactive protein in ethnic C hinese population in T aiwan
Huang, C., Chung, C., Leu, H., Lin, T., Chung, W., Wu, T.-C., Huang, P., Lin, S., Pan, W., & Chen, J. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12067 · Cited by 16
C-Reactive Protein and Prognosis in Diabetes: Getting to the Heart of the Matter
Sattar, N. A., & Hingorani, A. D. (2009) · Diabetes · doi:10.2337/db08-1788 · Cited by 15
Association of Bilirubin With Cardiovascular Outcomes
Kronenberg, F. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.957399 · Cited by 15
Tran, M. A., Cho, B. A., Izadmehr, S., Yoo, S., Youssef, D., Anker, J. F., Farkas, A. M., Figueiredo, I., Lee, K., Ananthanarayanan, A., et al. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-1774 · Cited by 17
Wang, J.-J., Zheng, Z., & Zhang, Y. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s466469 · Cited by 14
Inflammation in coronary atherosclerosis: diagnosis and treatment
Occhipinti, G., Brugaletta, S., Abbate, A., Pedicino, D., Buono, M. G. D., Vinci, R., Biondi‐Zoccai, G., Sabaté, M., Angiolillo, D. J., & Liuzzo, G. (2025) · Heart · doi:10.1136/heartjnl-2024-325408 · Cited by 16
Metadata
- Authors
- Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G.
- Affiliations
- University of Copenhagen (DK)
- Herlev Hospital (DK)
- Rigshospitalet (DK)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-30
- Volume
- 359
- Issue
- 18
- Pages
- 1897-1908
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2081615427
- Cited by
- 839
- References
- 36
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 21 · 2023: 21 · 2022: 26 · 2021: 25 · 2020: 33 · 2019: 25 · 2018: 28 · 2017: 40 · 2016: 48 · 2015: 44 · 2014: 61 · 2013: 56 · 2012: 76
- FWCI
- 102.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- C-reactive protein, ischemic heart disease, ischemic cerebrovascular disease, ischemic vascular disease, CRP gene polymorphisms, apolipoprotein E, high-sensitivity CRP, genetic association, cholesterol levels, causal relationship
- MeSH terms
- C-Reactive Protein, Cerebrovascular Disorders, Cross-Sectional Studies, Female, Humans, Male, Polymorphism, Genetic, Risk Factors, Cohort Studies, Biomarkers, Myocardial Ischemia, Genetic Predisposition to Disease, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.